Valneva SE Research and Development Expense
Valneva SE (VALN) reported Research and Development Expense of EUR 85.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-17
- Valneva SE research and development expense for the quarter ending 2025-12-31 was 25.57M EUR, a 0.01% decline year-over-year.
- Valneva SE research and development expense for the quarter ending 2025-09-30 was 27.29M EUR, a 44.50% increase year-over-year.
- Valneva SE research and development expense for the quarter ending 2025-06-30 was 17.49M EUR, a 5.65% increase year-over-year.
- Valneva SE research and development expense for the quarter ending 2025-03-31 was 14.95M EUR, a 13.88% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 9 month | Research And Development Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | 25.57M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-17 | 52.86M EUR derived: sum of 2 quarters · filed 2026-03-17 | 70.35M EUR derived: sum of 3 quarters · filed 2026-03-17 | 85.30M EUR 20-F · filed 2026-03-17 |
| 2025-09-30 | 27.29M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-20 | 44.78M EUR derived: sum of 2 quarters · filed 2025-11-20 | 59.73M EUR 6-K · filed 2025-11-20 | 85.31M EUR derived: sum of 4 quarters · filed 2026-03-17 |
| 2025-06-30 | 17.49M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-12 | 32.44M EUR 6-K · filed 2025-08-12 | 58.02M EUR derived: sum of 3 quarters · filed 2026-03-17 | 76.90M EUR derived: sum of 4 quarters · filed 2026-03-17 |
| 2025-03-31 | 14.95M EUR 6-K · filed 2025-05-07 | 40.53M EUR derived: sum of 2 quarters · filed 2026-03-17 | 59.41M EUR derived: sum of 3 quarters · filed 2026-03-17 | 75.97M EUR derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-12-31 | 25.58M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-17 | 44.46M EUR derived: sum of 2 quarters · filed 2026-03-17 | 61.01M EUR derived: sum of 3 quarters · filed 2026-03-17 | 74.14M EUR 20-F · filed 2026-03-17 |
| 2024-09-30 | 18.88M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-20 | 35.44M EUR derived: sum of 2 quarters · filed 2025-11-20 | 48.57M EUR 6-K · filed 2025-11-20 | 66.24M EUR derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | 16.55M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-12 | 29.68M EUR 6-K · filed 2025-08-12 | 47.36M EUR derived: sum of 3 quarters · filed 2026-03-17 | 63.60M EUR derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | 13.13M EUR 6-K · filed 2025-05-07 | 30.80M EUR derived: sum of 2 quarters · filed 2026-03-17 | 47.05M EUR derived: sum of 3 quarters · filed 2026-03-17 | 58.96M EUR derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | 17.67M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-17 | 33.92M EUR derived: sum of 2 quarters · filed 2026-03-17 | 45.83M EUR derived: sum of 3 quarters · filed 2026-03-17 | 59.89M EUR 20-F · filed 2026-03-17 |
| 2023-09-30 | 16.24M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-07 | 28.16M EUR derived: sum of 2 quarters · filed 2024-11-07 | 42.22M EUR 6-K · filed 2024-11-07 | 71.76M EUR derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-06-30 | 11.91M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-08-13 | 25.98M EUR 6-K · filed 2024-08-13 | 55.52M EUR derived: sum of 3 quarters · filed 2025-03-24 | 79.02M EUR derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-03-31 | 14.06M EUR 6-K · filed 2024-05-07 | 43.60M EUR derived: sum of 2 quarters · filed 2025-03-24 | 67.10M EUR derived: sum of 3 quarters · filed 2025-03-24 | 98.30M EUR derived: sum of 4 quarters · filed 2025-03-24 |
| 2022-12-31 | 29.54M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-24 | 53.04M EUR derived: sum of 2 quarters · filed 2025-03-24 | 84.23M EUR derived: sum of 3 quarters · filed 2025-03-24 | 104.92M EUR 20-F · filed 2025-03-24 |
| 2022-09-30 | 23.50M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-09 | 54.70M EUR derived: sum of 2 quarters · filed 2023-11-09 | 75.39M EUR 6-K · filed 2023-11-09 | 131.43M EUR derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | 31.19M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-21 | 51.88M EUR 6-K · filed 2023-09-21 | 107.93M EUR derived: sum of 3 quarters · filed 2024-03-22 | 146.43M EUR derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | 20.69M EUR 6-K · filed 2023-05-04 | 76.74M EUR derived: sum of 2 quarters · filed 2024-03-22 | 115.23M EUR derived: sum of 3 quarters · filed 2024-03-22 | 166.24M EUR derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | 56.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-03-22 | 94.55M EUR derived: sum of 2 quarters · filed 2024-03-22 | 145.55M EUR derived: sum of 3 quarters · filed 2024-03-22 | 173.28M EUR 20-F · filed 2024-03-22 |
| 2021-09-30 | 38.50M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-10 | 89.50M EUR derived: sum of 2 quarters · filed 2022-11-10 | 117.23M EUR 6-K · filed 2022-11-10 | |
| 2021-06-30 | 51.01M EUR derived: 6-K 6 month − 6-K/A 3 month · filed 2022-08-12 | 78.74M EUR 6-K · filed 2022-08-12 | ||
| 2021-03-31 | 27.73M EUR 6-K/A · filed 2022-08-12 | |||
| 2020-12-31 | 84.45M EUR 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 38.02M EUR 20-F · filed 2022-03-24 |